相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
Anne Godier et al.
ANESTHESIOLOGY (2012)
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
Raphael Marlu et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism
Thomas Mavrakanas et al.
PHARMACOLOGY & THERAPEUTICS (2011)
CLINICAL EXPERIENCE WITH A SWEDISH FACTOR IX CONCENTRATE
Inga Marie Nilsson et al.
ACTA MEDICA SCANDINAVICA (2010)
Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects
Brett E. Skolnick et al.
BLOOD (2010)
Determination of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry
G. Rohde
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Anticoagulants and their reversal
Sam Schulman et al.
TRANSFUSION MEDICINE REVIEWS (2007)
New anti-thrombotic agents: Emphasis on hemorrhagic complications and their management
HJ Ng et al.
SEMINARS IN HEMATOLOGY (2006)
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers
NR Bijsterveld et al.
CIRCULATION (2002)
Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor
M Elg et al.
THROMBOSIS RESEARCH (2001)
Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits
M Elg et al.
THROMBOSIS RESEARCH (2001)
分享论文
